Name:  [**Known lastname 9685**], [**Known firstname 448**] D                Unit No:  [**Numeric Identifier 9686**]  Admission Date:  [**2115-6-4**]     Discharge Date:  [**2115-6-10**]  Date of Birth:   [**2063-9-29**]     Sex:  M  Service:  MEDICATIONS ON ADMISSION:  Naprosyn 500 [**Hospital1 **].
Diffuse hypokinesis, LMCA normal, left anterior descending artery, LCX, RCA minimal irregularity.
At that time, the patient was given three doses of metoprolol 5 mg IV and an additional dose of 25 mg of metoprolol po and remains in atrial fibrillation.
The patient was given 0.25 mg of digoxin IV.
The patient received an additional dose that day of 0.25 mcg of digoxin, became therapeutic on digoxin with a level of 1.4 and was then maintained on 0.125 mg of digoxin po.
However, once the site placement was opened, the vasculature was deemed unsuitable for pacemaker placement, and pacemaker was not placed.
Anticoagulation:  Due to the patient's atrial fibrillation, the patient was anticoagulated with Heparin during the course of the admission and the patient was started on Coumadin 5 mg q hs for long-term anticoagulation.
The patient was then begun on Plavix 80 mg subQ twice a day and was deemed ready for discharge to be followed up for anticoagulation as an outpatient with the next dose of Coumadin to be 7.5.
The patient developed a 6 cm x 6 cm left upper chest hematoma at the site of incision for attempted pacemaker placement.
The patient was started on captopril and metoprolol.
Ankylosing spondylitis:  The patient was continued on Naprosyn 500 mg [**Hospital1 **].
Naproxen 500 mg [**Hospital1 **].
Thiamine 100 mg q day.
Folic acid 1 mg q day.
Multivitamin one capsule q day.
Protonix 40 mg q day.
Lisinopril 5 mg q day.
Warfarin 7.5 mg q hs.
Toprol XL 50 mg q day.
Lovenox 80 mg [**Hospital1 **] subcutaneous.
Digoxin 125 mcg q day.
